Research graph
References from Pilot study: Initial investigation suggests differences in EMT-associated gene expression in breast tumor regions. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Unresolved reference
External reference
10.3322/caac.21754
10.3322/caac.21754 · External reference
10.3322/caac.21754
10.3322/caac.21754 · External reference
10.3322/caac.21718
10.3322/caac.21718 · External reference
10.1038/nrc3896
10.1038/nrc3896 · External reference
Disparities in breast cancer and African ancestry: a global perspective
10.1111/tbj.12369 · 2015 · External reference
10.1371/journal.pone.0004531
10.1371/journal.pone.0004531 · External reference
10.1016/j.csbj.2023.06.019 · Admitted local publication
10.1093/jnci/djaa215
10.1093/jnci/djaa215 · External reference
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy
10.1038/s41523-023-00547-w · 2023 · External reference
Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix
10.3390/cancers13040713 · 2021 · External reference
10.1016/j.addr.2015.12.017
10.1016/j.addr.2015.12.017 · External reference
10.1126/science.1234850
10.1126/science.1234850 · External reference
10.1016/j.semcdb.2021.09.010
10.1016/j.semcdb.2021.09.010 · External reference
10.3390/jcm5070065
10.3390/jcm5070065 · External reference
10.1016/j.cell.2008.03.027
10.1016/j.cell.2008.03.027 · External reference
10.1016/j.cell.2004.06.006
10.1016/j.cell.2004.06.006 · External reference
Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings
10.1093/carcin/bgx037 · 2017 · External reference
10.1016/j.cell.2019.02.048
10.1016/j.cell.2019.02.048 · External reference
The contribution of race to breast tumor microenvironment composition and disease progression
2020 · External reference
10.1038/538161a
10.1038/538161a · External reference
10.1186/s13058-022-01551-x
10.1186/s13058-022-01551-x · External reference
Experimental models as refined translational tools for breast cancer research
10.3390/scipharm88030032 · 2020 · External reference
Theory and practice of integrating machine learning and conventional statistics in medical data analysis
10.3390/diagnostics12102526 · 2022 · External reference
10.1021/acs.chemrev.3c00189
10.1021/acs.chemrev.3c00189 · External reference
Unresolved reference
External reference
10.1109/csci49370.2019.00110
10.1109/csci49370.2019.00110 · External reference
10.1016/j.compbiomed.2020.104089
10.1016/j.compbiomed.2020.104089 · External reference
New machine learning applications to accelerate personalized medicine in breast cancer: rise of the support vector machines
10.1089/omi.2020.0001 · 2020 · External reference
The impact of sample non-normality on ANOVA and alternative methods
10.1111/j.2044-8317.2012.02047.x · 2013 · External reference
10.18637/jss.v025.i01
10.18637/jss.v025.i01 · External reference
Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4
10.1002/1878-0261.12319 · 2018 · External reference
Macrophage-secreted S100A4 supports breast cancer metastasis by remodeling the extracellular matrix in the premetastatic niche
10.1155/2022/9895504 · 2022 · External reference
MMP9: a tough target for targeted therapy for cancer
10.3390/cancers14071847 · 2022 · External reference
The Function of SUMOylation and its role in the development of cancer cells under stress conditions: a systematic review
10.1155/2020/8835714 · 2020 · External reference
SUMO losing balance: SUMO proteases disrupt SUMO homeostasis to facilitate cancer development and progression
10.1177/1947601910382555 · 2010 · External reference
10.1038/sj.onc.1208210
10.1038/sj.onc.1208210 · External reference
Interleukin-10: a double-edged sword in breast cancer
10.4103/tcmj.tcmj_162_20 · 2021 · External reference
10.1038/s41467-019-09234-6
10.1038/s41467-019-09234-6 · External reference
High tumor budding count is associated with adverse clinicopathologic features and poor prognosis in breast carcinoma
10.1016/j.humpath.2017.06.008 · 2017 · External reference
10.3390/ijms22041821
10.3390/ijms22041821 · External reference
Tumor-associated macrophages: key players in triple-negative breast cancer
10.3389/fonc.2022.772615 · 2022 · External reference
10.1016/j.imlet.2009.02.011
10.1016/j.imlet.2009.02.011 · External reference
10.2217/nnm.14.13
10.2217/nnm.14.13 · External reference
10.1038/75556
10.1038/75556 · External reference
10.1093/bioinformatics/btr260
10.1093/bioinformatics/btr260 · External reference
10.1093/nar/28.1.27
10.1093/nar/28.1.27 · External reference
Exploring heterogeneous expression of beta-actin (ACTB) in bladder cancer by producing a monoclonal antibody 6D6
10.1186/s12894-024-01489-6 · 2024 · External reference
